Načítá se...
NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825
INTRODUCTION: RTOG 0825 randomized 621 newly-diagnosed glioblastoma patients to treatment with or without bevacizumab, in addition to standard-of-care radiotherapy plus concurrent/adjuvant temozolomide. No significant difference was seen between the treatment arms in overall survival (OS), and the d...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692677/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.649 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|